کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2580099 1561601 2015 14 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
ترجمه فارسی عنوان
عوامل رشد می تواند سلول های سیگنالینگ در پیشرفت سرطان پروستات را به دنبال داشته باشد: پیامدهای کشف عوامل سرطان پروستات
کلمات کلیدی
سرطان پروستات، گزارش های بالینی، عوامل رشد، مهار کننده ها، سیگنالینگ
موضوعات مرتبط
علوم زیستی و بیوفناوری علوم محیط زیست بهداشت، سم شناسی و جهش زایی
چکیده انگلیسی


• Prostate cancer is the sixth foremost origin of cancer-related death in men.
• Approved drugs suffer from common problems of resistance and side effects.
• Evidence frame the role of growth factors in prostate cancer signalling.

Cancer is one of the leading causes of mortality amongst world’s population, in which prostate cancer is one of the most encountered malignancies among men. Globally, it is the sixth leading cause of cancer-related death in men. Prostate cancer is more prevalent in the developed world and is increasing at alarming rates in the developing countries. Prostate cancer is mostly a very sluggish progressing disease, caused by the overproduction of steroidal hormones like dihydrotestosterone or due to over-expression of enzymes such as 5-α-reductase. Various studies have revealed that growth factors play a crucial role in the progression of prostate cancer as they act either by directly elevating the level of steroidal hormones or upregulating enzyme efficacy by the active feedback mechanism. Presently, treatment options for prostate cancer include radiotherapy, surgery and chemotherapy. If treatment is done with prevailing traditional chemotherapy; it leads to resistance and development of androgen-independent prostate cancer that further complicates the situation with no cure option left. The current review article is an attempt to cover and establish an understanding of some major signalling pathways intervened through survival factors (IGF-1R), growth factors (TGF-α, EGF), Wnt, Hedgehog, interleukin, cytokinins and death factor receptor which are frequently dysregulated in prostate cancer. This will enable the researchers to design and develop better therapeutic strategies targeting growth factors and their cross talks mediated prostate cancer cell signalling.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Chemico-Biological Interactions - Volume 240, 5 October 2015, Pages 120–133
نویسندگان
, , , , , ,